LONDON (Reuters) - Sanofi-Aventis and Bristol-Myers Squibb , which are just recovering from defeating generic competition to their top-selling Plavix drug in the United States, now face a similar ...
New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel. Clopidogrel, currently sold under the brand name Plavix® ...
The Food and Drug Administration on Tuesday said a Canadian company could sell a generic version of the anticoagulant Plavix, the biggest-selling drug for , the developer of Plavix and the marketing ...
News of the expanded indication comes during a showdown between the marketer/manufacturer of the drug, Bristol-Myers Squibb (BMS)/Sanofi-Aventis, and Canadian drug company Apotex, which started ...
Clopidogrel is prescribed to help prevent cardiovascular events such as heart attack and stroke in certain adults. It’s a generic medication that's available as the brand-name drug Plavix. The drug ...
CHICAGO -- For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more effective and at least as safe as aspirin monotherapy in a high-risk ...
Immense interest has been expressed by clinicians and researchers in understanding clopidogrel nonresponsiveness. Of particular importance is the potential risk incurred by patients with ...
Researchers at the European Society of Cardiology Congress reported that the blood thinner clopidogrel should replace aspirin as a routine pill for preventing heart attacks and strokes for people with ...
Please provide your email address to receive an email when new articles are posted on . Patients with MI with nonobstructive coronary arteries, or MINOCA, have fewer recurrent events than those with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results